In-vivo animation of midazolam-induced electrocorticographic changes in humans.
Previous human studies have demonstrated that midazolam-induced signal changes on scalp EEG recording include widespread augmentation of sigma-oscillations and that the amplitude of such oscillations is correlated to the severity of midazolam-induced amnesia. Still unanswered questions include whether midazolam-induced sigma-augmentation also involves the medial temporal region, which plays a role in memory encoding. Taking advantage of rare and unique opportunities to monitor neuronal activities using intracranial electrocorticography (ECoG) recording, we determined how intravenous administration of midazolam elicited spectral frequency changes in the human cerebral cortex, including the medial temporal region. We studied three children with focal epilepsy who underwent subdural electrode placement and extraoperative ECoG recording for subsequent resection of the seizure focus; an intravenous bolus of midazolam was given to abort an ongoing simple partial seizure or to provide sedation prior to induction of general anesthesia. 'Midazolam-induced ECoG frequency alteration' in sites distant from the seizure focus was sequentially animated on their individual three-dimensional MR images. The common ECoG changes induced by midazolam included gradual augmentation of sigma-oscillations (12-16 Hz) in the widespread non-epileptic regions, including the medial temporal region. The spatial and temporal alteration of ECoG spectral frequency pattern can be appreciated via animation movies. Midazolam-induced sigma-augmentation was observed in the medial temporal region in our relatively small cohort of human subjects. In-vivo animation of ECoG spectral measures provided a unique situation to study the effect of midazolam on neuronal processing in the deep brain regions.
Nishida
Masaaki
M
Dept of Pediatrics, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan 48201, USA.
Sood
Sandeep
S
Asano
Eishi
E
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000293:Adolescent; D000647:Amnesia / Q000139:chemically induced / Q000503:physiopathology; D018686:Anesthetics, Intravenous / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D001683:Biological Clocks / Q000187:drug effects / Q000502:physiology; D001931:Brain Mapping / Q000379:methods; D002648:Child; D015331:Cohort Studies; D004569:Electroencephalography / Q000379:methods*; D018728:Entorhinal Cortex / Q000187:drug effects / Q000502:physiology; D004833:Epilepsy, Temporal Lobe / Q000503:physiopathology / Q000601:surgery; D005071:Evoked Potentials / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006624:Hippocampus / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D008874:Midazolam / Q000494:pharmacology*; D009040:Motion Pictures; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D020534:Parahippocampal Gyrus / Q000187:drug effects / Q000502:physiology; D012815:Signal Processing, Computer-Assisted; D013702:Temporal Lobe / Q000187:drug effects* / Q000502:physiology
D018686:Anesthetics, Intravenous; D000927:Anticonvulsants; D008874:Midazolam